ストックスクリーナーアプリを入手
10.62
1.77%
0.185
前日終値:
$10.44
開ける：
$10.58
24時間の取引高:
115.41K
Relative Volume:
0.92
時価総額：
$284.03M
収益：
$50.51M
当期純損益:
$-29.63M
株価収益率:
-9.2722
EPS:
-1.1459
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+6.30%
1か月 パフォーマンス:
-6.80%
6か月 パフォーマンス:
-22.16%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$10.44
$10.90
1週間の範囲:
$8.50
$10.90
52週間の値動き範囲:
$8.50
$17.19
Carlsmed Inc Stock (CARL) Company Profile
Compare CARL vs VEEV, TEM, BTSG, HQY, WAY
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CARL
Carlsmed Inc
|
10.62 | 279.08M | 50.51M | -29.63M | 0 | -1.1459 |
VEEV
Veeva Systems Inc
|
165.01 | 25.98B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
54.70 | 8.89B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
45.42 | 8.89B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
82.94 | 6.87B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
23.34 | 4.30B | 1.10B | 112.09M | 283.19M | 0.6096 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-18 | 開始されました | BTIG Research | Buy |
| 2025-08-18 | 開始されました | BofA Securities | Buy |
| 2025-08-18 | 開始されました | Goldman | Buy |
| 2025-08-18 | 開始されました | Piper Sandler | Overweight |
| 2025-08-18 | 開始されました | Truist | Buy |
Carlsmed Inc (CARL) 最新ニュース
Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026 - The Manila Times
Top Carlsmed (CARL) Competitors 2026 - MarketBeat
Carlsmed Showcases Personalized Spine Fusion Gains, Cervical Expansion and Medicare Tailwinds at Needham Conf - Yahoo Finance
The Goldman Sachs Group Has Lowered Expectations for Carlsmed (NASDAQ:CARL) Stock Price - Defense World
Carlsmed (CARL) Analyst Rating: Goldman Sachs Lowers Price Targe - GuruFocus
Carlsmed (NASDAQ:CARL) Price Target Lowered to $17.00 at The Goldman Sachs Group - MarketBeat
CARL.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CARL.O PE Ratio & Valuation, Is CARL.O Overvalued - Intellectia AI
CARL Technical Analysis & Stock Price Forecast - Intellectia AI
CARL News & Events - Intellectia AI
CARL.O Technical Analysis & Stock Price Forecast - Intellectia AI
Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference - Bitget
Carlsmed (NASDAQ:CARL) Upgraded at Zacks Research - Defense World
Carlsmed (NASDAQ:CARL) Upgraded by Zacks Research to Hold Rating - MarketBeat
Carlsmed, Inc. (NASDAQ:CARL) Receives Average Rating of "Hold" from Analysts - MarketBeat
Carlsmed reports Q4, FY 2025 revenue above estimate - MSN
Carlsmed, Inc.: Fundamental Analysis and Financial Ratings | I82 | US14280C1053 - marketscreener.com
Carlsmed Poised for Positive Growth Trajectory - San Diego Business Journal
Stryker, THINK Surgical and Carlsmed Named Winners of 2026 OMTEC® Excellence Awards - The Providence Journal
Carlsmed joins Russell 2000 Index following Q3 IPO - MSN
Head-To-Head Comparison: Carlsmed (CARL) vs. Its Rivals - Defense World
Comparing Carlsmed (CARL) & The Competition - Defense World
Head to Head Review: Carlsmed (CARL) and The Competition - Defense World
Carlsmed Earnings Call Highlights Rapid Growth, Rising Costs - TipRanks
Carlsmed Stock Down 6% Since IPO But Goldman Bullish And Predicts 35% Upside Potential — Retail Traders Stay Bearish - MSN
Carlsmed (CARL) versus The Competition Head to Head Analysis - Defense World
Carlsmed unveils custom cervical plating tech - MSN
Carlsmed (CARL) vs. Its Peers Financial Survey - Defense World
Carlsmed Unveils Personalized Spine Platform, Targets $70M-$75.5M 2025 Revenue at Conference - Defense World
Contrasting Carlsmed (CARL) & Its Peers - Defense World
Carlsmed (CARL) vs. Its Competitors Head-To-Head Contrast - Defense World
Carlsmed (CARL) versus The Competition Financial Contrast - Defense World
CARLSMED CEO Michael Cordonnier Sells Shares - TradingView
Contrasting Carlsmed (CARL) & Its Rivals - Defense World
CARL: Personalized spine surgery platform posts 86% annual growth and expands into cervical market - TradingView
CARL: Personalized spine surgery platform drives rapid growth, clinical success, and strong reimbursement - TradingView
Carlsmed (CARL) vs. Its Rivals Critical Survey - Defense World
Brokerages Set Carlsmed, Inc. (NASDAQ:CARL) Target Price at $21.33 - Defense World
Carlsmed (CARL) versus Its Peers Financial Contrast - Defense World
Carlsmed (NASDAQ:CARL) Cut to “Strong Sell” at Zacks Research - Defense World
Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Wave Life Sciences (WVE) and Carlsmed, Inc. (CARL) - The Globe and Mail
Carlsmed, Inc. (NASDAQ:CARL) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Carlsmed (NASDAQ:CARL) Lowered to Strong Sell Rating by Zacks Research - MarketBeat
Head to Head Survey: Carlsmed (CARL) versus Its Competitors - Defense World
Carlsmed (CARL) Revenue Growth At 85.9% Tests Bearish Profitability Narratives - simplywall.st
Carlsmed Q4 2025 revenue up 61% to USD 15.2M - Medical Buyer
Carlsmed Q4 Earnings Call Highlights - MarketBeat
Carlsmed, Inc. Reports Strong Q4 2025 Earnings and Growth Outlook - Intellectia AI
Carlsmed Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Carlsmed Inc (NASDAQ:CARL) Reports Q4 Revenue Beat and Narrower-Than-Expected Loss - ChartMill
Earnings call transcript: Carlsmed reports strong revenue, stock dips Q4 2025 - Investing.com
Carlsmed Inc (CARL) 財務データ
収益
当期純利益
現金流量
EPS
Carlsmed Inc (CARL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Cordonnier Michael | CEO, President |
Mar 02 '26 |
Option Exercise |
0.34 |
197,855 |
66,281 |
1,554,501 |
| Cordonnier Michael | CEO, President |
Mar 02 '26 |
Sale |
13.29 |
197,855 |
2,629,889 |
1,356,646 |
0.14%
大文字化:
|
ボリューム (24 時間):